The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Quest Diagnostics Inc

NYSE: DGX
Last

(U.S.) $67.81

Today's change-0.13 -0.19%
Updated December 26 3:48 PM EST. Delayed by at least 15 minutes.
 

Quest Diagnostics Inc

NYSE: DGX
Last

(U.S.) $67.81

Today's change-0.13 -0.19%
Updated December 26 3:48 PM EST. Delayed by at least 15 minutes.

Quest Diagnostics Inc down (U.S.)$0.13

Quest Diagnostics Inc closed lower Friday, dropping (U.S.)$0.13 or 0.19% to (U.S.)$67.81. Over the last five days, shares have gained 2.22% and 26.65% year to date. Shares have outperformed the S&P 500 by 12.38% during the last year.

Key company metrics

  • Open(U.S.) $68.00
  • Previous close(U.S.) $67.94
  • High(U.S.) $68.37
  • Low(U.S.) $67.59
  • Bid / Ask(U.S.) $67.80 / (U.S.) $67.82
  • YTD % change+26.65%
  • Volume637,150
  • Average volume (10-day)1,352,966
  • Average volume (1-month)1,332,092
  • Average volume (3-month)1,673,100
  • 52-week range(U.S.) $50.46 to (U.S.) $68.45
  • Beta0.76
  • Trailing P/E19.51×
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $1.32
  • Dividend yield1.95%
  • Trailing EPS(U.S.) $3.48
Updated December 26 3:48 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+7.44%

Based on its net profit margin of 7.44%, Quest Diagnostics Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.10%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue1,9041,9021,7461,756
Total other revenue--------
Total revenue1,9041,9021,7461,756
Gross profit733732653694
Total cost of revenue1,1711,1701,0931,062
Total operating expense1,6481,6401,5381,487
Selling / general / administrative437434411423
Research & development--------
Depreciation / amortization24252220
Interest expense (income), net operating--------
Unusual expense (income)161012-18
Other operating expenses, total0100
Operating income256262208270
Interest income (expense), net non-operating-42-42-40-40
Gain (loss) on sale of assets--------
Other--------
Income before tax221229176238
Income after tax139142111151
Income tax, total82876586
Net income129133104143
Total adjustments to net income-10-1-1
Net income before extra. items129133104143
Minority interest-10-9-7-8
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items128133103143
Inc. avail. to common incl. extra. items128133103142
Diluted net income128133103142
Dilution adjustment--------
Diluted weighted average shares145145145148
Diluted EPS excluding extraordinary itemsvalue per share0.880.920.710.97
Dividends per sharevalue per share0.330.330.300.30
Diluted normalized EPSvalue per share0.950.960.760.89